Shopping Cart
- Remove All
- Your shopping cart is currently empty
Mavodelpar (REN001), a selective PPARδ agonist, effectively suppresses glomerular injury and renal fibrosis. It is utilized in the research of primary mitochondrial myopathies (PMM) and long-chain fatty acid oxidation disorders (LC-FAOD).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 1.586 € | 1-2 weeks | |
50 mg | 2.071 € | 1-2 weeks | |
100 mg | 2.660 € | 1-2 weeks |
Description | Mavodelpar (REN001), a selective PPARδ agonist, effectively suppresses glomerular injury and renal fibrosis. It is utilized in the research of primary mitochondrial myopathies (PMM) and long-chain fatty acid oxidation disorders (LC-FAOD). |
Alias | REN001, HPP593 |
Molecular Weight | 537.55 |
Formula | C31H29FNNaO5 |
Cas No. | 1604815-32-8 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.